Roquette Commits to BioPharma Market

LESTREM, France, March 14, 2017 /PRNewswire/ --

Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries 

Roquette, a global leader in innovative plant-based pharmaceutical ingredients, announces its commitment to provide new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. 

(Logo: )

New product offerings are low endotoxin, multi-compendial grade materials for cell culture and biologic drug formulations.These products extend Roquette's commitment to helping customers save and sustain patient's lives.

"As a long-time leader in excipients and active ingredients for the pharmaceutical market, Roquette is proud to be part of this major therapeutic progress and is excited to introduce several new products in the U.S., Europe and Asia," said Paul Smaltz, VP of Global Business Unit Pharma.

"We have three new brands coming to the market under the names LYCADEX(R) BioPharma dextrose, PEARLITOL(R) BioPharma mannitol and NEOSORB(R) BioPharma sorbitol with a plan to continue adding to the portfolio," said Kelsey Achenbach, Pharma Marketing Director. "Customers now have an alternative option with a partner who is an established manufacturer and has sole custody of the supply chain when it comes to materials for biopharmaceuticals."

This investment reaffirms the company's strategic initiatives to develop specialties for Pharma, Food, Nutrition and Health markets to accelerate global growth. The BioPharma market launch addresses the growing customer demand for biologic drugs worldwide. These protein-based drugs can be game-changing by having the ability to put rheumatoid arthritis into remission and transform many cancers into treatable conditions.

Consider Roquette, the bioLOGICAL choice.

To learn more about Roquette biopharma offerings visit

About Roquette:  

A family-owned Group serving customers globally, Roquette is a leader in specialty food ingredients and pharmaceutical excipients. The products and solutions developed by the Group deliver proven technological, nutritional and health benefits precisely tailored to the pharma, nutrition, food and selected industry markets. Roquette's offer is produced from plant-based raw materials such as corn, wheat, potatoes and peas. Since its foundation over 80 years ago, the Group's growth has been based on innovation, a passion for the job and a commitment to achieve. Roquette operates in over 100 countries, has a turnover of around 3.3 billion euros and currently employs more than 8,000 people worldwide.



CONTACT: Carole Petitjean,, + 33 (0)3 21 6336 00, Sophie Delannay-Wong Sai Chun,, + 33(0)3 21 63 36 43, Groupe ROQUETTE, 62080 Lestrem Cedex France, Tel:+33-321-633-600

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234